Suppressing Inflammation for the Treatment of Diabetic Retinopathy and Age-Related Macular Degeneration: Dazdotuftide As a Potential New Multitarget Therapeutic Candidate

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2023 Jun 28

PMID 37371657

Authors

Brice Nguedia Vofo

Itay Chowers

Affiliations

Soon will be listed here.

Abstract

Diabetic retinopathy (DR) and age-related macular degeneration (AMD) are major causes of blindness globally. The primary treatment option for DME and neovascular AMD (nAMD) is anti-vascular endothelial growth factor (VEGF) compounds, but this treatment modality often yields insufficient results, and monthly injections can place a burden on the health system and patients. Although various inflammatory pathways and mediators have been recognized as key players in the development of DR and AMD, there are limited treatment options targeting these pathways. Molecular pathways that are interlinked, or triggers of multiple inflammatory pathways, could be promising targets for drug development. This review focuses on the role of inflammation in the pathogenesis of DME and AMD and presents current anti-inflammatory compounds, as well as a potential multitarget anti-inflammatory compound (dazdotuftide) that could be a candidate treatment option for the management of DME and AMD.

Citing Articles

Dexamethasone implant for refractory macular edema secondary to diabetic retinopathy and retinal vein occlusion.

Zhong Y, Tang C, Zhang L, Zhang X, Liu S Int J Ophthalmol. 2024; 17(10):1837-1842.

PMID: 39430031 PMC: 11422367. DOI: 10.18240/ijo.2024.10.09.

Kavain Alleviates Choroidal Neovascularization Via Decreasing the Activity of the HIF-1α/VEGF-A/VEGFR2 Signaling Pathway and Inhibiting Inflammation.

Chen X, Qin X, Bai W, Ren J, Yu Y, Nie H Adv Pharm Bull. 2024; 14(2):469-482.

PMID: 39206403 PMC: 11347728. DOI: 10.34172/apb.2024.036.

A promising case of preclinical-clinical translation: β-adrenoceptor blockade from the oxygen-induced retinopathy model to retinopathy of prematurity.

Cammalleri M, Filippi L, Dal Monte M, Bagnoli P Front Physiol. 2024; 15:1408605.

PMID: 38938747 PMC: 11208707. DOI: 10.3389/fphys.2024.1408605.

Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases.

Titz B, Siebourg-Polster J, Bartolo F, Lavergne V, Jiang Z, Gayan J Transl Vis Sci Technol. 2024; 13(6):17.

PMID: 38913008 PMC: 11205237. DOI: 10.1167/tvst.13.6.17.

CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis.

Szukiewicz D Int J Mol Sci. 2024; 25(9).

PMID: 38731899 PMC: 11083509. DOI: 10.3390/ijms25094679.

References

Kuppermann B, Blumenkranz M, Haller J, Williams G, Weinberg D, Chou C . Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol. 2007; 125(3):309-17. DOI: 10.1001/archopht.125.3.309. View

Dasu M, Devaraj S, Zhao L, Hwang D, Jialal I . High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes. 2008; 57(11):3090-8. PMC: 2570406. DOI: 10.2337/db08-0564. View

Marie M, Bigot K, Angebault C, Barrau C, Gondouin P, Pagan D . Light action spectrum on oxidative stress and mitochondrial damage in A2E-loaded retinal pigment epithelium cells. Cell Death Dis. 2018; 9(3):287. PMC: 5833722. DOI: 10.1038/s41419-018-0331-5. View

Voronov E, Carmi Y, Apte R . The role IL-1 in tumor-mediated angiogenesis. Front Physiol. 2014; 5:114. PMC: 3975103. DOI: 10.3389/fphys.2014.00114. View

Cao X, Shen D, Patel M, Tuo J, Johnson T, Olsen T . Macrophage polarization in the maculae of age-related macular degeneration: a pilot study. Pathol Int. 2011; 61(9):528-35. PMC: 3292787. DOI: 10.1111/j.1440-1827.2011.02695.x. View

Mohammad G, Siddiquei M, Othman A, Al-Shabrawey M, Abu El-Asrar A . High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina. Exp Eye Res. 2012; 107:101-9. DOI: 10.1016/j.exer.2012.12.009. View

Bashi T, Shovman O, Fridkin M, Volkov A, Barshack I, Blank M . Novel therapeutic compound tuftsin-phosphorylcholine attenuates collagen-induced arthritis. Clin Exp Immunol. 2015; 184(1):19-28. PMC: 4778098. DOI: 10.1111/cei.12745. View

. Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial. The DAMAD Study Group. Diabetes. 1989; 38(4):491-8. View

Merida S, Sancho-Tello M, Almansa I, Desco C, Peris C, Moreno M . Bevacizumab Diminishes Inflammation in an Acute Endotoxin-Induced Uveitis Model. Front Pharmacol. 2018; 9:649. PMC: 6018210. DOI: 10.3389/fphar.2018.00649. View

10.

Koya D, King G . Protein kinase C activation and the development of diabetic complications. Diabetes. 1998; 47(6):859-66. DOI: 10.2337/diabetes.47.6.859. View

11.

Li W, Jin L, Cui Y, Nie A, Xie N, Liang G . Bone marrow mesenchymal stem cells-induced exosomal microRNA-486-3p protects against diabetic retinopathy through TLR4/NF-κB axis repression. J Endocrinol Invest. 2020; 44(6):1193-1207. DOI: 10.1007/s40618-020-01405-3. View

12.

Hageman G, Anderson D, Johnson L, Hancox L, Taiber A, Hardisty L . A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A. 2005; 102(20):7227-32. PMC: 1088171. DOI: 10.1073/pnas.0501536102. View

13.

Wheeler K, Jena M, Pradhan B, Nayak N, Das S, Hsu C . VEGF may contribute to macrophage recruitment and M2 polarization in the decidua. PLoS One. 2018; 13(1):e0191040. PMC: 5764356. DOI: 10.1371/journal.pone.0191040. View

14.

Patil N, Mihalache A, Hatamnejad A, Popovic M, Kertes P, Muni R . Intravitreal Steroids Compared with Anti-VEGF Treatment for Diabetic Macular Edema: A Meta-Analysis. Ophthalmol Retina. 2022; 7(4):289-299. DOI: 10.1016/j.oret.2022.10.008. View

15.

Ferris 3rd F, Wilkinson C, Bird A, Chakravarthy U, Chew E, Csaky K . Clinical classification of age-related macular degeneration. Ophthalmology. 2013; 120(4):844-51. PMC: 11551519. DOI: 10.1016/j.ophtha.2012.10.036. View

16.

Huang J, Wang J, Li Y, Wang Z, Chu M, Wang Y . Tuftsin: A Natural Molecule Against SARS-CoV-2 Infection. Front Mol Biosci. 2022; 9:859162. PMC: 8984176. DOI: 10.3389/fmolb.2022.859162. View

17.

Friedman S, Almukhtar T, Baker C, Glassman A, Elman M, Bressler N . Topical nepafenec in eyes with noncentral diabetic macular edema. Retina. 2015; 35(5):944-56. PMC: 4408212. DOI: 10.1097/IAE.0000000000000403. View

18.

Gillies M, Sutter F, Simpson J, Larsson J, Ali H, Zhu M . Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology. 2006; 113(9):1533-8. DOI: 10.1016/j.ophtha.2006.02.065. View

19.

Ishida S, Shinoda K, Kawashima S, Oguchi Y, Okada Y, Ikeda E . Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2000; 41(7):1649-56. View

20.

Fritsche L, Igl W, Cooke Bailey J, Grassmann F, Sengupta S, Bragg-Gresham J . A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2015; 48(2):134-43. PMC: 4745342. DOI: 10.1038/ng.3448. View